An experimental pill aimed at cell stress did not slow ALS in a placebo-controlled trial
In the HEALEY ALS Platform Trial, 325 participants took DNL343 or placebo for 24 weeks. The drug, which targets the cell's integrated stress response, did not slow loss of function or improve…